Trapidil

This classification denotes a phosphodiesterase inhibitor with the molecular formula C10H15N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EYG5Y6355E, chemically known as 7-diethylamino-5-methyl-s-triazolo(1,5-a)pyrimidine but generally known as trapidil, which bears US NIH Compound Identifier 5531. European Medicines Agency schedules Trapidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11220MIG. The term TRAPIDIL is an International Non-Proprietary Name. World Health Organization schedules trapidil in its Anatomical Therapeutic Chemical (ATC) Classification. TRAPIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trapidil under HS 29335995 and SITC 51576. As of Q4 2014, TRAPIDIL remains the US FDA Preferred Term for this commodity. Trapidil bears US NLM identifiers UMLS ID C0040779 and NCI Concept Code C66615. SMILES: CCN(CC)C1=CC(=NC2=NC=NN12)C.